News
Research Brings Hope To Neurodegenerative Disease Sufferers
The development of a neurodegenerative disease in mice is slowed down by a novel therapy, according to researchers. The ground-breaking study may provide hope for...
News
NHS Should Not Employ 5 COVID Therapies, According To NICE
Five COVID-19 therapies, including Merck & Co.'s antiviral tablet for high-risk patients, have been recommended for discontinuation by Britain's agency that decides whether medications may...
Drug Research
IGBA- 2022 WHO Biosimilar Roadmap Facilitates Accessibility
According to the new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline from the International Generic and Biosimilar Medicines Association (IGBA),...
News
Abu Dhabi Airports Joins Pharma.Aero As Strategic Member
As a strategic member representing the Middle East, Abu Dhabi Airports has joined Pharma.Aero, a global member network for life science and medical technology manufacturers,...
Drug Research
GHIT Fund Invests ¥790M On Neglected Tropical Disease Items
Two neglected tropical illnesses, lymphatic filariasis and onchocerciasis, will receive a combined investment of about 790-million-yen ($5.3 million) from the Global Health Innovative Technology (GHIT)...
Clinical Trials
A New Initiative To Assess Clinical Trials Carbon Footprint
The Clinical Trials Environmental Impact Community of Interest (CoI), a cooperative effort that aims to determine the carbon footprint of centralised and decentralised clinical trials,...
Clinical Trials
Seven Pharma CEOs Team Together To Accomplish Emission Aims
Seven CEOs of pharmaceutical companies, including GSK, AstraZeneca, Merck, Roche, Novo Nordisk, Samsung Biologics, and Sanofi, have launched a collaborative effort to meet short-term emission reduction goals...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.